Home › Politics › White House drops Heidi Overton’s FDA nomination
Politics

White House drops Heidi Overton’s FDA nomination

White House drops Heidi Overton’s FDA nomination
Key Points

The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday. The decision comes a day before the Senate Health Committee was scheduled to vote on whether to advance her nomination to the full Senate for confirmation. Axios first reported the White House’s decision.

WASHINGTON — The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday. The decision comes a day before the Senate Health Committee was scheduled to vote on whether to advance her nomination to the full Senate for confirmation. Axios first reported the White House’s decision. The move follows weeks of doubts from key Republicans on Health, Education, Pensions and Labor Committee. Sen. Bill Cassidy of Louisiana, the committee’s chairman, questioned whether Overton — a preventive medicine doctor who serves as a domestic policy official in the White House — had enough experience to lead the agency. Prior to joining the White House, Overton worked as chief policy officer at the conservative think tank America First Policy Institute. Sen. Susan Collins, R-Maine, told NBC News last week that she was undecided and had “not taken a position,” saying she needed “to get some answers on various things.” Overton has praised the Supreme Court’s decision to overturn Roe v. Wade and called for strict restrictions on medication abortion. FOR SUBSCRIBERSAll these tech outages all at once FOR SUBSCRIBERSOn Twitch, a small audience could be enough to make a living The FDA is set to finish its safety review of mifepristone in March, one of the most consequential decisions the agency faces. FOR SUBSCRIBERSAll these tech outages all at once FOR SUBSCRIBERSOn Twitch, a small audience could be enough to make a living Overton’s nomination was already working against a tight window. Democrats take control of the Senate in January, when she would have to be renominated, and her chances of being confirmed then would be slim. The FDA has been without a permanent commissioner since Dr. Marty Makary resigned in May, in part because of the administration’s decision to authorize several fruit-flavored vaping products. The vacancy adds to a long period of upheaval at the nation’s top health agencies. The Centers for Disease Control and Prevention went nearly a year without a permanent director after Health Secretary Robert F. Kennedy Jr. removed Susan Monarez just 29 days into the job last year. Trump’s first pick for that role, former congressman Dave Weldon, couldn’t secure enough Republican support, and the agency cycled through a series of acting leaders before the Senate confirmed Dr. Erica Schwartz in August.
White House (ORG) Heidi Overton’s (PERSON) FDA (ORG) WASHINGTON (LOCATION) The White House (ORG) Heidi Overton (PERSON) the Food and Drug Administration (ORG) the Senate Health Committee (ORG) Senate (ORG) the White House’s (ORG) Republicans (ORG) Health, Education, Pensions and Labor Committee (ORG) Bill Cassidy (PERSON) Louisiana (LOCATION) Overton (PERSON)
Originally published by NBC News Read original →